Larimar Therapeutics, Inc. (LRMR) NASDAQ

5.95

+2.26(+61.25%)

Updated at February 25 04:00PM

Currency In USD

Valuation

Market Cap237.06M
Enterprise Value208.96M
P/E Ratio-3.53
PEG Ratio0.15
Price/Sales Ratio0
Price/Book Ratio3.35
Enterprise/Revenue0
Enterprise/EBITDA-3.08

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.7
Return On Equity-0.92

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-90.57M
Net Income-80.6M
Diluted EPS-1.32

Balance Sheet

Total Cash175.44M
Total Cash/Share2.24
Total Debt4.35M
Total Debt/Equity0.03
Current Ratio4.06
Book Value Per Share1.78

Price History

52-Week Change101.69
52-Week High6.42
52-Week Low1.61
Moving Average 50 Days3.51
Moving Average 200 Days3.47

Statistics

Average Volume1.2M
Shares Outstanding85.59M
% Held by Institutions92.47

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateMay 29, 2020